Drug Development Committee

ATAC’s Drug Development Committee (DDC) works with government, academia and the pharmaceutical industry to provide a community perspective into the development of new HIV drugs and the utilization of HIV therapies.

Andy Kaytes and Michael Dorosh

Kevin Fisher and Fred Schaich
Vice Co-Chairs

Jeff Taylor
DDC Representative to the Board of Directors

To become a DDC member, you must apply to ATAC and be accepted as an ATAC member. Please note: to apply for DDC membership, you will be asked to answer questions related to financial disclosure of any income received from the pharmaceutical industry. For more information about becoming a member, please click here.


AIDS/HIV Glossary of Terms from the U.S. National Institutes of Health
AIDSinfo Drugs Database fact sheets on HIV-related drugs
Clinical Trials for HIV/AIDS Drugs from